Private Wealth Management Group’s Fennec Pharmaceuticals FENC Stock Holding History

Private Wealth Management Group’s Portfolio FENC Stock Details FENC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.66K	Sell	247 -150	-38%	-$1.23K	﹤0.01%	1065
2026 Q1	$2.44K	Buy	397 +150	+61%	+$1.16K	﹤0.01%	1022
2025 Q4	$1.9K	Hold	247	–	–	﹤0.01%	1101
2025 Q3	$2.31K	Hold	247	–	–	﹤0.01%	1069
2025 Q2	$2.05K	Sell	247 -182	-42%	-$1.25K	﹤0.01%	1077
2025 Q1	$2.61K	Buy	429 +182	+74%	+$1.17K	﹤0.01%	967
2024 Q4	$1.56K	Buy	+247	New	+$1.26K	﹤0.01%	1181

Other funds holding FENC

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

SCM

Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PCA

Prospect Capital Advisors Sausalito, California $220M AUM 60.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Private Wealth Management Group's FENC Position: Q2 2026 in Review

Private Wealth Management Group reduced its Fennec Pharmaceuticals (FENC) stake by 38% in Q2 2026, selling an estimated $1.23K and leaving 247 shares worth $2.66K. The position accounts for ﹤0.01% of the portfolio, ranked #1065.

Private Wealth Management Group first reported a position in FENC in Q4 2024 and has held it in 7 quarters since. 104 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

Private Wealth Management Group held 247 shares of Fennec Pharmaceuticals worth $2.66K as of Q2 2026.
Private Wealth Management Group sold 150 Fennec Pharmaceuticals shares in Q2 2026, an estimated $1.23K.
Fennec Pharmaceuticals made up ﹤0.01% of Private Wealth Management Group's portfolio in Q2 2026, its #1065 holding.
Private Wealth Management Group first reported a position in Fennec Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
104 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on Private Wealth Management Group's 13F filing for Q2 2026, filed 27 Jul 2026.